According to filings with the U.S. Securities and Exchange Commission, ProrataAI is raising up to $2,500,000.00 in new funding. Sources indicate that as part of senior management Executive, Susan Aledort played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Prometheum is raising up to $20,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Aaron Kaplan played a key…
According to filings with the U.S. Securities and Exchange Commission, Plural Labs is raising up to $6,072,129.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Samuel Weaver played a…
According to filings with the U.S. Securities and Exchange Commission, Phoam Labs is raising up to $2,250,000.00 in new funding. Sources indicate that as part of senior management Chairman, Ian Butcher played a key role…
According to filings with the U.S. Securities and Exchange Commission, PBS Biotech is raising up to $16,999,997.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Brian Lee played a…
According to filings with the U.S. Securities and Exchange Commission, OWP Pharmaceuticals is raising up to $2,730,773.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Steve Bourne played a…
According to filings with the U.S. Securities and Exchange Commission, OrderProtection.com is raising up to $2,200,000.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Dustin Marsden played a key…
According to filings with the U.S. Securities and Exchange Commission, Ordaos is raising up to $4,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Longo played a key…
According to filings with the U.S. Securities and Exchange Commission, Orbion Space Technology is raising up to $3,000,000.00 in new funding. Sources indicate that as part of senior management President, Lyon King played a key…
According to filings with the U.S. Securities and Exchange Commission, ONL Therapeutics is raising up to $65,000,002.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Esposito played a…